Veterinary Medicines

Biocom P Vet

Authorised
  • Clostridium botulinum, type C, toxoid
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
  • Mink enteritis virus, type 1, strain United, Inactivated
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
Download as PDF

Product identification

Medicine name:
Biocom P Vet
BIOCOM P VET SUSPENSION INYECTABLE PARA VISONES
Active substance:
  • Clostridium botulinum, type C, toxoid
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
  • Mink enteritis virus, type 1, strain United, Inactivated
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
Target species:
  • Mink
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium botulinum, type C, toxoid
    40.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, type 1, strain United, Inactivated
    1.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
    1.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Polyethylene bottle containing 500 ml (500 doses), closed with a rubber stopper and sealed with an aluminum cap.
  • Polyethylene bottle containing 250 ml (250 doses), closed with a rubber stopper and sealed with an aluminum cap.
  • Polyethylene bottle containing 100 ml (100 doses), closed with a rubber stopper and sealed with an aluminum cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • United Vaccines Holding B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cooeperative Federation Of Nobel Animal Keepers Nederasselt U.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 3603 ESP
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0227/001
Concerned member states:
  • Denmark
  • Finland
  • Greece
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Romania
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download